Nomura Holdings, Inc. (NMR) Stock Forecast
NMR analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $11.22 average of analyst targets
- Upside to target
- +21.4% from the latest close
- Next earnings
- October 28, 2026 EPS estimate $0.20
- 52-week range
- $6.92 – $10.86
NMR analyst ratings
1 analystsNumber of analysts at each rating.
NMR price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NMR earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.20 | $0.20 | $0.20 | $0.20 | −2.4% | 1 |
| Next quarter (Dec '26) | $0.22 | $0.22 | $0.22 | $0.20 | +8.4% | 1 |
| Current fiscal year (FY2027) | $0.98 | $0.98 | $0.98 | $0.77 | +27.2% | 1 |
| Next fiscal year (FY2028) | $0.98 | $0.98 | $0.98 | $0.98 | −0.6% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NMR revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $658.00B | $658.00B | $658.00B | +27.7% | 1 |
| Next quarter (Dec '26) | $661.00B | $661.00B | $661.00B | +19.8% | 1 |
| Current fiscal year (FY2027) | $2.47T | $2.30T | $2.68T | +250.3% | 5 |
| Next fiscal year (FY2028) | $2.47T | $2.27T | $2.71T | +0.2% | 5 |
NMR EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NMR revenue: reported and forecast
NMR EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.18 | $0.18 | $0.20 | $0.20 | $0.20 | +8.8% | 0 up · 1 down |
| Next quarter (Dec '26) | $0.19 | $0.18 | $0.21 | $0.21 | $0.22 | +18.6% | 1 up · 0 down |
| Current fiscal year (FY2027) | $0.78 | $0.80 | $0.93 | $0.93 | $0.98 | +25.7% | 1 up · 0 down |
| Next fiscal year (FY2028) | $0.81 | $0.82 | $0.95 | $0.95 | $0.98 | +21.0% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NMR earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NMR beat in 6 of 12.
What analysts expect from NMR
1 analysts cover Nomura; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $11.22, 21.4% above the latest close of $9.24. Analysts expect earnings of $0.98 per share for FY2027, +27.2% from a year earlier. For FY2028 the average estimate is $0.98 per share on revenue of $2.47 trillion. Nomura beat the EPS estimate in 6 of the last 12 quarters.
Related: NMR income statement, NMR key metrics, NMR chart. See the NMR stock overview for the latest quote and news.
NMR forecast FAQ
What is Nomura's price target?
The average analyst price target for Nomura is $11.22, 21.4% above the latest close of $9.24.
Is Nomura a buy, hold or sell?
Of 1 analysts covering Nomura, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Nomura's EPS forecast?
Analysts forecast $0.98 per share for FY2027 (range $0.98 to $0.98); for FY2028 the estimate is $0.98.
What is Nomura's revenue forecast?
The average revenue estimate for FY2027 is $2.47 trillion, growth of 250.3%; for FY2028 it is $2.47 trillion.
When does Nomura report earnings?
Nomura is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 before the market opens; the EPS estimate is $0.20.
Does Nomura usually beat earnings estimates?
Nomura reported EPS at or above the analyst estimate in 6 of the last 12 quarters.